Related references
Note: Only part of the references are listed.Dialogue between VE-Cadherin and Sphingosine 1 Phosphate Receptor1 (S1PR1) for Protecting Endothelial Functions
Olivia Garnier et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)
Endothelial-Specific Loss of Sphingosine-1-Phosphate Receptor 1 Increases Vascular Permeability and Exacerbates Bleomycin-induced Pulmonary Fibrosis
Rachel S. Knipe et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2022)
Distinct GEFs Couple S1PR1 to Rac for Endothelial Barrier Enhancement and Lymphocyte Trafficking
Ilaria Del Gaudio et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2022)
Sphingosine-1-Phosphate (S1P) and S1P Signaling Pathway Modulators, from Current Insights to Future Perspectives
Gary Alvarez Bravo et al.
CELLS (2022)
Mortality and survival in idiopathic pulmonary fibrosis: a systematic review and meta-analysis
Qiang Zheng et al.
ERJ OPEN RESEARCH (2022)
Sphingolipids in Lung Pathology in the Coronavirus Disease Era: A Review of Sphingolipid Involvement in the Pathogenesis of Lung Damage
Saad A. Khan et al.
FRONTIERS IN PHYSIOLOGY (2021)
Targeting Sphingosine-1-Phosphate Signaling in Immune-Mediated Diseases: Beyond Multiple Sclerosis
Tamara Perez-Jeldres et al.
DRUGS (2021)
Chronic Obstructive Pulmonary Disease and the Cardiovascular System: Vascular Repair and Regeneration as a Therapeutic Target
Srikanth Karnati et al.
FRONTIERS IN CARDIOVASCULAR MEDICINE (2021)
Characterization of the heterogeneity of endothelial cells in bleomycin-induced lung fibrosis using single-cell RNA sequencing
Xiucheng Liu et al.
ANGIOGENESIS (2021)
Idiopathic pulmonary fibrosis: Disease mechanisms and drug development
Paolo Spagnolo et al.
PHARMACOLOGY & THERAPEUTICS (2021)
Global incidence and prevalence of idiopathic pulmonary fibrosis
Toby M. Maher et al.
RESPIRATORY RESEARCH (2021)
Endothelial heterogeneity across distinct vascular beds during homeostasis and inflammation
Ankit Jambusaria et al.
ELIFE (2020)
Vascular permeability in the fibrotic lung
Clemens K. Probst et al.
EUROPEAN RESPIRATORY JOURNAL (2020)
Sphingosine Kinase 1/S1P Signaling Contributes to Pulmonary Fibrosis by Activating Hippo/YAP Pathway and Mitochondrial Reactive Oxygen Species in Lung Fibroblasts
Long Shuang Huang et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Alveolar cells under mechanical stressed niche: critical contributors to pulmonary fibrosis
Juntang Yang et al.
MOLECULAR MEDICINE (2020)
Selective Inactivation of Intracellular BiP/GRP78 Attenuates Endothelial Inflammation and Permeability in Acute Lung Injury
Antony Leonard et al.
SCIENTIFIC REPORTS (2019)
PASSING THE VASCULAR BARRIER: ENDOTHELIAL SIGNALING PROCESSES CONTROLLING EXTRAVASATION
Nina Wettschureck et al.
PHYSIOLOGICAL REVIEWS (2019)
The role of endothelial cells in cystic fibrosis
M. Declercq et al.
JOURNAL OF CYSTIC FIBROSIS (2019)
VEGF and FGF-2: Promising targets for the treatment of respiratory disorders
Ankit P. Laddha et al.
RESPIRATORY MEDICINE (2019)
Lung Repair and Regeneration in ARDS Role of PECAM1 and Wnt Signaling
Jesus Villar et al.
CHEST (2019)
The Rho Kinase Isoforms ROCK1 and ROCK2 Each Contribute to the Development of Experimental Pulmonary Fibrosis
Rachel S. Knipe et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2018)
High-density lipoprotein (HDL) promotes angiogenesis via S1P3-dependent VEGFR2 activation
Fengyan Jin et al.
ANGIOGENESIS (2018)
Idiopathic pulmonary fibrosis: Epithelial-mesenchymal interactions and emerging therapeutic targets
Justin C. Hewlett et al.
MATRIX BIOLOGY (2018)
Sphingosine-1-phosphate receptor-2 facilitates pulmonary fibrosis through potentiating IL-13 pathway in macrophages
Juanjuan Zhao et al.
PLOS ONE (2018)
Interplay between tight junctions & adherens junctions
Hannah K. Campbell et al.
EXPERIMENTAL CELL RESEARCH (2017)
FTY720 promotes pulmonary fibrosis when administered during the remodelling phase following a bleomycin-induced lung injury
David R. Gendron et al.
PULMONARY PHARMACOLOGY & THERAPEUTICS (2017)
Effect of pirfenidone on mortality: pooled analyses and meta-analyses of clinical trials in idiopathic pulmonary fibrosis
Steven D. Nathan et al.
LANCET RESPIRATORY MEDICINE (2017)
Sepsis-Associated Encephalopathy: The Blood-Brain Barrier and the Sphingolipid Rheostat
Stephen J. Kuperberg et al.
FRONTIERS IN IMMUNOLOGY (2017)
Uncoupling of the profibrotic and hemostatic effects of thrombin in lung fibrosis
Barry S. Shea et al.
JCI INSIGHT (2017)
Long-term (up to 4.5 years) treatment with fingolimod in multiple sclerosis: results from the extension of the randomised TRANSFORMS study
Jeffrey A. Cohen et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2016)
Drug Treatment of Idiopathic Pulmonary Fibrosis Systematic Review and Network Meta-Analysis
William J. Canestaro et al.
CHEST (2016)
Oral fingolimod in primary progressive multiple sclerosis (INFORMS): a phase 3, randomised, double-blind, placebo-controlled trial
Fred Lublin et al.
LANCET (2016)
The role of sphingolipids in endothelial barrier function
Peter L. Jernigan et al.
BIOLOGICAL CHEMISTRY (2015)
Vascular permeability-the essentials
Lena Claesson-Welsh
UPSALA JOURNAL OF MEDICAL SCIENCES (2015)
New Therapeutic Targets in Idiopathic Pulmonary Fibrosis Aiming to Rein in Runaway Wound-Healing Responses
Neil Ahluwalia et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2014)
Mechanical control of the endothelial barrier
Joppe Oldenburg et al.
CELL AND TISSUE RESEARCH (2014)
FTY720, a Sphingosine-1 Phosphate Receptor Modulator, Improves Liver Fibrosis in a Mouse Model by Impairing the Motility of Bone Marrow-Derived Mesenchymal Stem Cells
Yaxian Kong et al.
INFLAMMATION (2014)
FTY720 attenuates paraquat-induced lung injury in mice
Jie Qian et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2014)
Vascular Endothelial Growth Factor Signaling in Hypoxia and Inflammation
S. Ramakrishnan et al.
JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2014)
Safety and efficacy of fingolimod in patients with relapsing-remitting multiple sclerosis (FREEDOMS II): a double-blind, randomised, placebo-controlled, phase 3 trial
Peter A. Calabresi et al.
LANCET NEUROLOGY (2014)
Sphingosine-1-Phosphate, FTY720, and Sphingosine-1-Phosphate Receptors in the Pathobiology of Acute Lung Injury
Viswanathan Natarajan et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2013)
Sphingosine 1-Phosphate (S1P) Receptor Agonists Mediate Pro-fibrotic Responses in Normal Human Lung Fibroblasts via S1P2 and S1P3 Receptors and Smad-independent Signaling
Katrin Sobel et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
FTY720 prevents progression of renal fibrosis by inhibiting renal microvasculature endothelial dysfunction in a rat model of chronic kidney disease
Haifeng Ni et al.
JOURNAL OF MOLECULAR HISTOLOGY (2013)
Sphingosine-1-phosphate is increased in patients with idiopathic pulmonary fibrosis and mediates epithelial to mesenchymal transition
Javier Milara et al.
THORAX (2012)
Sphingomyelin synthase 2 (SMS2) deficiency attenuates LPS-induced lung injury
Satish Gowda et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2011)
HIF and the Lung Role of Hypoxia-inducible Factors in Pulmonary Development and Disease
Larissa A. Shimoda et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2011)
Differential involvement of ezrin/radixin/moesin proteins in sphingosine 1-phosphate-induced human pulmonary endothelial cell barrier enhancement
Djanybek M. Adyshev et al.
CELLULAR SIGNALLING (2011)
Dissociation of VE-PTP from VE-cadherin is required for leukocyte extravasation and for VEGF-induced vascular permeability in vivo
Andre Broermann et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2011)
Rho-associated kinase-dependent contraction of stress fibres and the organization of focal adhesions
Kazuo Katoh et al.
JOURNAL OF THE ROYAL SOCIETY INTERFACE (2011)
Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials
Paul W. Noble et al.
LANCET (2011)
Comparison of fingolimod with interferon beta-1a in relapsing-remitting multiple sclerosis: a randomised extension of the TRANSFORMS study
Bhupendra Khatri et al.
LANCET NEUROLOGY (2011)
Sphingosine 1-phosphate (S1P) Physiology and the effects of S1P receptor modulation
Timothy Hla et al.
NEUROLOGY (2011)
Intracellular S1P Generation Is Essential for S1P-Induced Motility of Human Lung Endothelial Cells: Role of Sphingosine Kinase 1 and S1P Lyase
Evgeny V. Berdyshev et al.
PLOS ONE (2011)
The Sphingosine-1 Phosphate receptor agonist FTY720 dose dependently affected endothelial integrity in vitro and aggravated ventilator-induced lung injury in mice
Holger Christian Mueller et al.
PULMONARY PHARMACOLOGY & THERAPEUTICS (2011)
Prolonged Exposure to Sphingosine 1-Phosphate Receptor-1 Agonists Exacerbates Vascular Leak, Fibrosis, and Mortality after Lung Injury
Barry S. Shea et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2010)
Differential Effects of Sphingosine 1-Phosphate Receptors on Airway and Vascular Barrier Function in the Murine Lung
Saad Sammani et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2010)
Regulation of Endothelial Permeability via Paracellular and Transcellular Transport Pathways
Yulia Komarova et al.
ANNUAL REVIEW OF PHYSIOLOGY (2010)
Pirfenidone in idiopathic pulmonary fibrosis
H. Taniguchi et al.
EUROPEAN RESPIRATORY JOURNAL (2010)
Sphingosine 1-Phosphate (S1P) Regulates Vascular Contraction via S1P3 Receptor: Investigation Based on a New S1P3 Receptor Antagonist
Akira Murakami et al.
MOLECULAR PHARMACOLOGY (2010)
Differential regulation of sphingosine kinases 1 and 2 in lung injury
Raj Wadgaonkar et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2009)
FTY720 (fingolimod) in Multiple Sclerosis: therapeutic effects in the immune and the central nervous system
Volker Brinkmann
BRITISH JOURNAL OF PHARMACOLOGY (2009)
MMP expression and abnormal lung permeability are important determinants of outcome in IPF
S. McKeown et al.
EUROPEAN RESPIRATORY JOURNAL (2009)
Activation of Rho Kinase Isoforms in Lung Endothelial Cells during Inflammation
Phyllus Y. Mong et al.
JOURNAL OF IMMUNOLOGY (2009)
Enhanced interaction between focal adhesion and adherens junction proteins: Involvement in sphingosine 1-phosphate-induced endothelial barrier enhancement
Xiaoguang Sun et al.
MICROVASCULAR RESEARCH (2009)
Vascular permeability, vascular hyperpermeability and angiogenesis
Janice A. Nagy et al.
ANGIOGENESIS (2008)
VE-PTP maintains the endothelial barrier via plakoglobin and becomes dissociated from VE-cadherin by leukocytes and by VEGF
Astrid F. Nottebaum et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2008)
Rho/Rho kinase is a key enzyme system involved in the angiotensin II signaling pathway of liver fibrosis and steatosis
Kumi Kitamura et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2007)
Evolving functions of endothelial cells in inflammation
Jordan S. Pober et al.
NATURE REVIEWS IMMUNOLOGY (2007)
Induction of vascular permeability by the sphingosine-1-phosphate receptor-2 (S1P2R) and its downstream effectors ROCK and PTEN
Teresa Sanchez et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2007)
Immunomodulator FTY720 induces myofibroblast differentiation via the lysophospholipid receptor S1P(3) and smad3 signaling
Christina D. Keller et al.
AMERICAN JOURNAL OF PATHOLOGY (2007)
Sphingosine 1-phosphate regulates cytoskeleton dynamics: Implications in its biological response
Chiara Donati et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2006)
Signaling mechanisms regulating endothelial permeability
D Mehta et al.
PHYSIOLOGICAL REVIEWS (2006)
The sphingosine and diacylglycerol kinase superfamily of signaling kinases: localization as a key to signaling function
Binks W. Wattenberg et al.
JOURNAL OF LIPID RESEARCH (2006)
Immune cell regulation and cardiovascular effects of sphingosine 1-phosphate receptor agonists in rodents are mediated via distinct receptor subtypes
M Forrest et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2004)
Structural and functional characteristics of S1P receptors
T Sanchez et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2004)
Pigment epithelium - derived factor in idiopathic pulmonary fibrosis - A role in aberrant angiogenesis
GP Cosgrove et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2004)
Angiogenic cytokines in patients with idiopathic interstitial pneumonia
NR Simler et al.
THORAX (2004)
Endothelial cell-to-cell junctions: Molecular organization and role in vascular homeostasis
G Bazzoni et al.
PHYSIOLOGICAL REVIEWS (2004)
Sphingosine 1-phosphate reduces vascular leak in murine and canine models of acute lung injury
BJ McVerry et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2004)
Protective effects of sphingosine 1-phosphate in murine endotoxin-induced inflammatory lung injury
XQ Peng et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2004)
Heterogeneous increase in CD34-positive alveolar capillaries in idiopathic pulmonary fibrosis
M Ebina et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2004)
The sphingosine 1-phosphate receptor S1P4 regulates cell shape and motility via coupling to Gi and G12/13
MH Gräler et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2003)
Rho GTPases and the regulation of endothelial permeability
B Wojciak-Stothard et al.
VASCULAR PHARMACOLOGY (2002)
Comparative analysis of human and rat S1P5 (edg8):: differential expression profiles and sensitivities to antagonists
A Niedernberg et al.
BIOCHEMICAL PHARMACOLOGY (2002)
Y-27632 prevents tubulointerstitial fibrosis in mouse kidneys with unilateral ureteral obstruction
K Nagatoya et al.
KIDNEY INTERNATIONAL (2002)
Sphingosine 1-phosphate promotes endothelial cell barrier integrity by Edg-dependent cytoskeletal rearrangement
JGN Garcia et al.
JOURNAL OF CLINICAL INVESTIGATION (2001)
Share Paper
